267 related articles for article (PubMed ID: 17240842)
1. [Studies of risk factors and preventive care for neuroleptic malignant syndrome].
Tanii H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):177-81. PubMed ID: 17240842
[TBL] [Abstract][Full Text] [Related]
2. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
3. Clinical risk factors for neuroleptic malignant syndrome.
Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
[TBL] [Abstract][Full Text] [Related]
4. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ; Wilborn CA
Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of summer amongst people with learning disabilities: neuroleptic malignant syndrome.
Fitzgerald B; Middleton JK; Cooper SA
J Intellect Disabil Res; 1997 Jun; 41 ( Pt 3)():273-7. PubMed ID: 9219078
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
Bellamy CJ; Kane-Gill SL; Falcione BA; Seybert AL
J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder.
Joshi PT; Capozzoli JA; Coyle JT
Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966
[TBL] [Abstract][Full Text] [Related]
8. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome: a preventive program.
Fernando ML; Manchanda R; Kirk C
J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827
[TBL] [Abstract][Full Text] [Related]
10. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
Tural U; Onder E
Psychiatry Clin Neurosci; 2010 Feb; 64(1):79-87. PubMed ID: 20416027
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
Wait SD; Ponce FA; Killory BD; Wallace D; Rekate HL
J Neurosurg Pediatr; 2009 Sep; 4(3):217-21. PubMed ID: 19772404
[TBL] [Abstract][Full Text] [Related]
14. Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients.
Shiloh R; Valevski A; Bodinger L; Misgav S; Aizenberg D; Dorfman-Etrog P; Weizman A; Munitz H
Int Clin Psychopharmacol; 2003 May; 18(3):147-9. PubMed ID: 12702893
[TBL] [Abstract][Full Text] [Related]
15. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
Andreassen MD; Pedersen S
Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
[TBL] [Abstract][Full Text] [Related]
16. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
Waldorf S
AANA J; 2003 Oct; 71(5):389-94. PubMed ID: 14625976
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome.
Bristow MF; Kohen D
Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome.
McHugh TP
J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome in Mexico.
Montoya A; Ocampo M; Torres-Ruiz A
Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
